NEW YORK (GenomeWeb News) - Sequenom today announced that it has signed several distribution deals outside of the US that will expand access to the firm's MaterniT21 PLUS testing service outside the United States.

The San Diego-based molecular diagnostics firm didn't disclose the name of any of the new distributors but said the deals cover Japan, Hong Kong, Czech Republic, Slovakia, the Netherlands; and Israel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.